Thomas A. Waldmann

Also affiliated with National Cancer Institute, Center for Cancer Research

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 23 papers. Top paper: “IL-15 in the Combination Immunotherapy of Cancer”.

IL-15 in the Combination Immunotherapy of Cancer

Frontiers in Immunology(2020)10.3389/fimmu.2020.00868

N/A

4.1DataRank · unranked

253 citations

Sigrid Dubois, Miloš D. Miljković, Kevin C. Conlon, Thomas A. Waldmann

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies

Blood Advances(2022)10.1182/bloodadvances.2021006440

N/A

0.756DataRank · unranked

21 citations

Sigrid Dubois, Jürgen R. Müller, Bonita R. Bryant, J. Elaine, Kevin C. Conlon +2 more

Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti‐tac

Annals of Neurology(1998)10.1002/ana.410440613

N/A

0.659DataRank · unranked

80 citations

Michael C. Levin, Ryuji Kubota, Richard N. Bamford, Alfred N. Flerlage, Samantha S. Soldan +11 more

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Blood Neoplasia(2024)10.1016/j.bneo.2024.100054

N/A

0.165DataRank · unranked

2 citations

Sigrid Dubois, Miloš D. Miljković, Samuel Y. Ng, Bonita R. Bryant, Rahul Lakhotia +8 more

A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-4137

N/A

0DataRank · unranked

27 citations

Yuquan Lin, Zhihui Song, Wenming Xiao, Liqi Chen, Jiejing Yin +6 more

Analysis of Human Natural Killer Cell Metabolism

Journal of Visualized Experiments(2020)10.3791/61466

N/A

0DataRank · unranked

7 citations

Thomas A. Waldmann, Olga M. Antón, Javier Traba

NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice

Cellular Immunology(2020)10.1016/j.cellimm.2020.104081

N/A

0DataRank · unranked

4 citations

Lionel Feigenbaum, Thomas A. Waldmann, Jürgen R. Müller, Sigrid Dubois

Engagement of lymphoma T cell receptors causes accelerated growth and the secretion of an NK cell-inhibitory factor

Cellular Immunology(2020)10.1016/j.cellimm.2020.104213

N/A

0DataRank · unranked

1 citations

Thomas A. Waldmann, Jürgen R. Müller, Sigrid Dubois

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Blood(2021)10.1182/blood.2021012734

N/A

0DataRank · unranked

41 citations

Sarvesh Kumar, Joji Shimono, Anusara Daenthanasanmak, Sigrid Dubois, Yuquan Lin +22 more

Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance

Frontiers in Immunology(2021)10.3389/fimmu.2021.657293

N/A

0DataRank · unranked

34 citations

Michael N. Sack, Thomas A. Waldmann, Olga M. Antón, Javier Traba

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002193

N/A

0DataRank · unranked

43 citations

Miloš D. Miljković, Thomas A. Fleisher, Stefania Pittaluga, Jennifer Hsu-Albert, Bonita R. Bryant +7 more

EGR1 Addiction in Diffuse Large B-cell Lymphoma

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0267

N/A

0DataRank · unranked

16 citations

Li Lü, Nguyet M. Hoang, Fen Zhu, Paul D. Bates, Anusara Daenthanasanmak +13 more

IL-15 Trans-Presentation Is an Autonomous, Antigen-Independent Process

The Journal of Immunology(2021)10.4049/jimmunol.2100277

N/A

0DataRank · unranked

11 citations

Julianna Volkó, Nikoletta Szalóki, Gábor Mocsár, Károly Jambrovics, Zoltán Balajthy +5 more

Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphomas in Mice

The Journal of Immunology(2021)10.4049/jimmunol.2001123

N/A

0DataRank · unranked

4 citations

Thomas A. Waldmann, Jürgen R. Müller, Sigrid Dubois

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

Translational Oncology(2020)10.1016/j.tranon.2020.100913

N/A

0DataRank · unranked

13 citations

Yuquan Lin, Meili Zhang, Bonita R. Bryant, Michael Petrus, Richard N. Bamford +5 more

IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-0496

N/A

0DataRank · unranked

16 citations

Richard N. Bamford, Elijah F. Edmondson, Thomas A. Waldmann, Wei Chen

Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia

Blood(2023)10.1182/blood.2022017643

N/A

0DataRank · unranked

17 citations

Karen K. Ballen, Lubomir Sokol, Christiane Querfeld, Ryotaro Nakamura, Anjali Mishra +7 more

Accessory cells precondition naïve T cells and regulatory T cells for cytokine-mediated proliferation

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2217562120

N/A

0DataRank · unranked

4 citations

Richard N. Bamford, Bonita R. Bryant, Yutaka Tagaya, Thomas A. Waldmann, Noriko Sato

Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma

Blood(2023)10.1182/blood.2022019166

N/A

0DataRank · unranked

6 citations

Wenjun Wu, Wei Wei, Wenming Xiao, Michelle Lei, Kathy Q. Cai +10 more

Data from IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors

(2023)10.1158/1078-0432.c.6531092

N/A

0DataRank · unranked

0 citations

Richard N. Bamford, Elijah F. Edmondson, Thomas A. Waldmann, Wei Chen

Data from IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors

(2023)10.1158/1078-0432.c.6531092.v1

N/A

0DataRank · unranked

0 citations

Richard N. Bamford, Elijah F. Edmondson, Thomas A. Waldmann, Wei Chen

Bench-to-bedside translation of interleukin-15 for immunotherapy: principles and challenges

Expert Opinion on Drug Delivery(2020)10.1080/17425247.2020.1764933

N/A

0DataRank · unranked

8 citations

Thomas A. Waldmann, Chalet Tan

Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2014470117

N/A

0DataRank · unranked

18 citations

Wei Wei, Wenming Xiao, Essel Dulaimi Al-Saleem, Reza Nejati, Liqi Chen +6 more